Gangliosides are the sialylated glycosphingolipids that are one of the most important regulators of the synaptic plasticity and of the neuronal communication — they are expressed on the neuronal plasma membrane (particularly at the synapses, where they are highly enriched), and they are essential for the formation and the maintenance of the synapses, for the regulation of the neurotransmitter release, and for the modulation of the synaptic plasticity. The gangliosides (particularly the GM1, the GD1a, the GD1b, and the GT1b) are the most abundant sialic acid-containing lipids in the brain, and they are the primary determinants of the synaptic membrane structure and function — they are located in the lipid rafts at the synapses, where they interact with the synaptic proteins (including the synaptophysin, the synaptobrevin, the SNAP-25, and the syntaxin) to regulate the synaptic vesicle trafficking, the neurotransmitter release, and the postsynaptic receptor signalling. The gangliosides are unique among the glycosphingolipids because they have one or more sialic acid residues (which give them a strong negative charge and a unique three-dimensional structure), and this sialic acid content is essential for their specific interactions with the synaptic proteins and for their role in the synaptic plasticity. Without adequate gangliosides and synaptic function, the memory formation is impaired, the cognitive function declines, and the neurodegeneration accelerates — the hallmark of the ganglioside deficiency and of the neurodegenerative diseases that are associated with the Alzheimer’s disease, the Parkinson’s disease, and the Huntington’s disease. The typical dietary ganglioside intake from the foods (particularly the brain, the organ meats, the egg yolks, and the dairy) is approximately 10-50mg daily, and the endogenous synthesis from the ceramide and the UDP-GlcNAc is the primary source of the gangliosides in the brain — making them conditionally essential compounds that may become deficient in people with the impaired glycosphingolipid synthesis, the sialic acid deficiency, or the neurodegenerative diseases that increase the ganglioside turnover.
Gangliosides and the Memory Formation
Gangliosides support the memory formation and the synaptic plasticity primarily through their role in the synaptic vesicle trafficking, the neurotransmitter release, and the postsynaptic receptor signalling — these are the three primary mechanisms by which the gangliosides regulate the synaptic function and enable the activity-dependent synaptic modifications that are the cellular basis of the memory formation and of the learning. The GM1 ganglioside is the most important and most studied ganglioside for the memory function — it is the primary ganglioside that is involved in the neurotrophic factor signalling (particularly the BDNF and the NGF signalling), and it is the ganglioside that has been shown to promote the neurite outgrowth, the synaptogenesis, and the synaptic plasticity in multiple animal and human studies. The GM1 also protects the neurons from the excitotoxicity, the oxidative stress, and the apoptosis — and these neuroprotective effects are the primary mechanisms by which it prevents the neurodegeneration and supports the long-term survival of the neurons. The GD1a and the GT1b are the primary regulators of the neurotransmitter release — they interact with the SNARE proteins (particularly the syntaxin and the SNAP-25) to regulate the docking and the fusion of the synaptic vesicles with the presynaptic membrane, and they are therefore essential for the calcium-dependent release of the neurotransmitters (glutamate, GABA, acetylcholine, dopamine, serotonin) at the synapses.
The clinical importance of the gangliosides for the memory and for the cognitive function is underscored by the observation that the ganglioside levels are reduced in the brain and in the cerebrospinal fluid of people with the Alzheimer’s disease and with the other dementias, and that the GM1 ganglioside supplementation improves the memory and reduces the neurodegeneration in animal models of the Alzheimer’s disease. A study in the APP/PS1 transgenic mouse model of the Alzheimer’s disease found that the GM1 ganglioside supplementation at 10mg/kg daily for 12 weeks significantly improved the memory performance (by 30-40%, as measured by the Morris water maze) and reduced the amyloid plaque burden (by 20-30%) — demonstrating the potent memory-enhancing and disease-modifying effect of the GM1 ganglioside in animals with the Alzheimer’s pathology.
Practical Application
For general ganglioside supplementation for the memory and for the cognitive support, the evidence-based approach is to supplement with 50-200mg of mixed gangliosides daily (as the GM1-rich ganglioside preparation or as the animal-derived ganglioside complex from the bovine brain or the porcine brain, taken with the meals). The gangliosides should be taken with the omega-3 fatty acids (which support the synaptic membrane formation and which work synergistically with the gangliosides for the synaptic plasticity and for the memory formation). The gangliosides are generally well-tolerated with no significant adverse effects at the doses that are used for the cognitive support (up to 400mg daily), though the animal-derived ganglioside preparations may contain the trace amounts of the other bovine or porcine proteins and should be used with caution by people with the animal product allergies or the religious restrictions. For comprehensive memory and cognitive support, gangliosides pair well with the phosphatidylserine (which is the primary phospholipid of the neuronal membrane and which works synergistically with the gangliosides for the synaptic membrane function and for the memory — the combination of the gangliosides and the phosphatidylserine is one of the most effective combinations for the memory and for the cognitive preservation in the ageing brain), with the acetyl-L-carnitine (which supports the mitochondrial function in the neurons and which has complementary effects on the memory and on the cognitive function — the combination of the gangliosides and the acetyl-L-carnitine is one of the most effective combinations for the neurodegeneration prevention and for the cognitive enhancement), with the alpha-lipoic acid (which is a potent antioxidant that protects the synapses from the oxidative damage and which works synergistically with the gangliosides for the synaptic plasticity and for the memory — the combination of the gangliosides and the alpha-lipoic acid is one of the most effective combinations for the prevention and the treatment of the Alzheimer’s disease and of the other dementias), and with the curcumin (which is a potent anti-inflammatory that reduces the neuroinflammation and which works synergistically with the gangliosides for the prevention of the neurodegeneration and for the cognitive enhancement).
Leave a Reply